What We Do

We use Failure Mode & Effects Analysis for evaluating medication packaging and labeling
Contact Us

The Medication Safety Board uses various tools and methodologies, including Failure Mode & Effects Analysis (FMEA), to evaluate the design of packaging and labeling to maximize safety during use. Our consultative services are provided to pharmaceutical, biotechnology, and technology companies in need of expert review, evaluation, and direction of the safe use of their products. Besides pre-marketing services, The Medication Safety Board works with pharmaceutical companies to provide post-marketing services that address potential or actual medication error concerns.